Suppr超能文献

组蛋白去甲基化酶 UTX 在食管鳞状细胞癌中的预后意义。

The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.

机构信息

Department of Hematology-Oncology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.

Department of Thoracic & Cardiovascular Surgery, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan.

出版信息

Int J Mol Sci. 2018 Jan 19;19(1):297. doi: 10.3390/ijms19010297.

Abstract

The dysregulation of the ubiquitously transcribed TPR gene on the X chromosome () has been reported to be involved in the oncogenesis of several types of cancers. However, the expression and significance of in esophageal squamous cell carcinoma (ESCC) remains largely undetermined. Immunohistochemistry was performed in 106 ESCC patients, and correlated with clinicopathological features and survival. The functional role of in ESCC cells was determined by -mediated siRNA. Univariate analyses showed that high expression was associated with superior overall survival (OS, = 0.011) and disease-free survival (DFS, = 0.01). overexpression was an independent prognosticator in multivariate analysis for OS ( = 0.013, hazard ratio = 1.996) and DFS ( = 0.009, hazard ratio = 1.972). The 5-year OS rates were 39% and 61% in patients with low expression and high expression of , respectively. Inhibition of endogenous in ESCC cells increased cell viability and BrdU incorporation, and decreased the expression of epithelial marker E-cadherin. Immunohistochemically, expression was also positively correlated with E-cadherin expression. High expression is independently associated with a better prognosis in patients with ESCC and downregulation of increases ESCC cell growth and decreases E-cadherin expression. Our results suggest that may be a novel therapeutic target for patients with ESCC.

摘要

TPR 基因在 X 染色体上的普遍转录失调已被报道与多种癌症的发生有关。然而,在食管鳞状细胞癌(ESCC)中, 的表达和意义在很大程度上仍未确定。我们对 106 例 ESCC 患者进行了免疫组织化学分析,并与临床病理特征和生存相关联。通过 介导的 siRNA 确定了 在 ESCC 细胞中的功能作用。单因素分析表明,高 表达与总生存(OS, = 0.011)和无病生存(DFS, = 0.01)的改善相关。在多因素分析中, 过表达是 OS( = 0.013,风险比 = 1.996)和 DFS( = 0.009,风险比 = 1.972)的独立预后因素。低表达和高表达 的患者的 5 年 OS 率分别为 39%和 61%。在 ESCC 细胞中抑制内源性 会增加细胞活力和 BrdU 掺入,并降低上皮标志物 E-钙黏蛋白的表达。免疫组织化学分析还表明, 表达与 E-钙黏蛋白表达呈正相关。高 表达与 ESCC 患者的较好预后独立相关,下调 会增加 ESCC 细胞的生长并降低 E-钙黏蛋白的表达。我们的结果表明, 可能是 ESCC 患者的一个新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e1/5796242/ae041ec06115/ijms-19-00297-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验